Warfarin sodium and Systemic sclerosis (scleroderma) - a phase IV clinical study of FDA data

Summary:

We study 65,999 people who have side effects when taking Warfarin sodium. Systemic sclerosis (scleroderma) is found, especially among people who are female, 60+ old, also take Tracleer and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people take Warfarin sodium and have Systemic sclerosis (scleroderma). It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

65,999 people reported to have side effects when taking Warfarin sodium.
Among them, 33 people (0.05%) have Systemic sclerosis (scleroderma).

What is Warfarin sodium?

Warfarin sodium has active ingredients of warfarin sodium. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 69,806 Warfarin sodium users.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 1,201 drugs and 830 conditions by eHealthMe. Currently, we are studying 10,602 people who have Systemic sclerosis (scleroderma).

Number of Warfarin sodium and Systemic sclerosis (scleroderma) reports submitted per year:

Could Warfarin sodium cause Systemic sclerosis (scleroderma)?

Gender of people who have Systemic sclerosis (scleroderma) when taking Warfarin sodium *:

female: 72.73 %
male: 27.27 %

Age of people who have Systemic sclerosis (scleroderma) when taking Warfarin sodium *:

Common drugs people take besides Warfarin sodium *:

Common side effects people have besides Systemic sclerosis (scleroderma) *:

Pulmonary Hypertension (increase in blood pressure in the lung artery): 10 people, 30.30%
Oedema Peripheral (superficial swelling): 6 people, 18.18%
Pleural Effusion (water on the lungs): 6 people, 18.18%
Pneumonia: 5 people, 15.15%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 15.15%
Breast Cancer: 5 people, 15.15%
Diarrhea: 5 people, 15.15%
Weakness: 5 people, 15.15%
Chest Pain: 4 people, 12.12%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 4 people, 12.12%

Common conditions people have *:

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 24.24%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 21.21%
Pain: 2 people, 6.06%
High Blood Cholesterol: 2 people, 6.06%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 3.03%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.03%
Renal Cancer Stage I (the tumour is 7 cm or smaller and is in the kidney only. it has not spread to the lymph nodes): 1 person, 3.03%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.03%
Indigestion: 1 person, 3.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Warfarin sodium and have Systemic sclerosis (scleroderma)?

Check whether Systemic sclerosis (scleroderma) is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Warfarin sodium side effects by duration, gender and age:

Warfarin sodium side effects (69,806 reports)

Systemic sclerosis (scleroderma) treatments and more:

Systemic sclerosis (scleroderma) (10,602 reports)

Common drugs associated with Systemic sclerosis (scleroderma):

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Warfarin sodium) and Warfarin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.